163 related articles for article (PubMed ID: 24051432)
1. A DNA vaccine targeting p42.3 induces protective antitumor immunity via eliciting cytotoxic CD8+T lymphocytes in a murine melanoma model.
Liu H; Geng S; Feng C; Xie X; Wu B; Chen X; Zou Q; Wang S; Cui J; Xing R; Li W; Lu Y; Wang B
Hum Vaccin Immunother; 2013 Oct; 9(10):2196-202. PubMed ID: 24051432
[TBL] [Abstract][Full Text] [Related]
2. A short hairpin RNA-based adjuvant targeting NF-κB repressor IκBα promotes migration of dermal dendritic cells to draining lymph nodes and antitumor CTL responses induced by DNA vaccination.
Gálvez-Cancino F; Roco J; Rojas-Colonelli N; Flores C; Murgas P; Cruz-Gómez S; Oyarce C; Varas-Godoy M; Sauma D; Lladser A
Vaccine; 2017 Jul; 35(33):4148-4154. PubMed ID: 28666759
[TBL] [Abstract][Full Text] [Related]
3. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
4. Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery.
Best SR; Peng S; Juang CM; Hung CF; Hannaman D; Saunders JR; Wu TC; Pai SI
Vaccine; 2009 Sep; 27(40):5450-9. PubMed ID: 19622402
[TBL] [Abstract][Full Text] [Related]
5. Heparanase DNA vaccine delivered by electroporation induces humoral immunity and cytoimmunity in animal models.
Fu J; Zhao B; Dong Z; Sun Y; Luan H; Shen X; Gao X; Gong F; Li S; Song H
Vaccine; 2012 Mar; 30(12):2187-96. PubMed ID: 22240343
[TBL] [Abstract][Full Text] [Related]
6. In vivo plasmid electroporation induces tumor antigen-specific CD8+ T-cell responses and delays tumor growth in a syngeneic mouse melanoma model.
Kalat M; Küpcü Z; Schüller S; Zalusky D; Zehetner M; Paster W; Schweighoffer T
Cancer Res; 2002 Oct; 62(19):5489-94. PubMed ID: 12359758
[TBL] [Abstract][Full Text] [Related]
7. Procyanidin, a kind of biological flavonoid, induces protective anti-tumor immunity and protects mice from lethal B16F10 challenge.
Zhang L; Wang S; Liu Z; Zhang L; Wang S; Wang B
Int Immunopharmacol; 2017 Jun; 47():251-258. PubMed ID: 28445856
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells.
Baghban Rahimi S; Mohebbi A; Vakilzadeh G; Biglari P; Razeghi Jahromi S; Mohebi SR; Shirian S; Gorji A; Ghaemi A
Arch Virol; 2018 Mar; 163(3):587-597. PubMed ID: 29149434
[TBL] [Abstract][Full Text] [Related]
9. Enhancing therapy of B16F10 melanoma efficacy through tumor vaccine expressing GPI-anchored IL-21 and secreting GM-CSF in mouse model.
Zhao F; Dou J; He XF; Wang J; Chu L; Hu W; Yu F; Hu K; Wu Y; Gu N
Vaccine; 2010 Apr; 28(16):2846-52. PubMed ID: 20153795
[TBL] [Abstract][Full Text] [Related]
10. Immunological protection against HPV16 E7-expressing human esophageal cancer cell challenge by a novel HPV16-E6/E7 fusion protein based-vaccine in a Hu-PBL-SCID mouse model.
Lu Y; Zhang Z; Liu Q; Liu B; Song X; Wang M; Zhao X; Zhao Q
Biol Pharm Bull; 2007 Jan; 30(1):150-6. PubMed ID: 17202676
[TBL] [Abstract][Full Text] [Related]
11. Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma.
Lladser A; Ljungberg K; Tufvesson H; Tazzari M; Roos AK; Quest AF; Kiessling R
Cancer Immunol Immunother; 2010 Jan; 59(1):81-92. PubMed ID: 19526360
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of melanoma: a dichotomy in the requirement for IFN-gamma in vaccine-induced antitumor immunity versus adoptive immunotherapy.
Winter H; Hu HM; McClain K; Urba WJ; Fox BA
J Immunol; 2001 Jun; 166(12):7370-80. PubMed ID: 11390488
[TBL] [Abstract][Full Text] [Related]
13. Potent systemic antitumor immunity induced by vaccination with chemotactic-prostate tumor associated antigen gene-modified tumor cell and blockade of B7-H1.
Li N; Qin H; Li X; Zhou C; Wang D; Ma W; Lin C; Zhang Y; Wang S; Zhang S
J Clin Immunol; 2007 Jan; 27(1):117-30. PubMed ID: 17180470
[TBL] [Abstract][Full Text] [Related]
14. Xenogeneic human p53 DNA vaccination by electroporation breaks immune tolerance to control murine tumors expressing mouse p53.
Soong RS; Trieu J; Lee SY; He L; Tsai YC; Wu TC; Hung CF
PLoS One; 2013; 8(2):e56912. PubMed ID: 23457640
[TBL] [Abstract][Full Text] [Related]
15. Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen.
Buchan S; Grønevik E; Mathiesen I; King CA; Stevenson FK; Rice J
J Immunol; 2005 May; 174(10):6292-8. PubMed ID: 15879128
[TBL] [Abstract][Full Text] [Related]
16. Treatment with mANT2 shRNA enhances antitumor therapeutic effects induced by MUC1 DNA vaccination.
Choi Y; Jeon YH; Jang JY; Chung JK; Kim CW
Mol Ther; 2011 May; 19(5):979-89. PubMed ID: 21063392
[TBL] [Abstract][Full Text] [Related]
17. Critical components of a DNA fusion vaccine able to induce protective cytotoxic T cells against a single epitope of a tumor antigen.
Rice J; Buchan S; Stevenson FK
J Immunol; 2002 Oct; 169(7):3908-13. PubMed ID: 12244189
[TBL] [Abstract][Full Text] [Related]
18. Non-replicating Newcastle Disease Virus as an adjuvant for DNA vaccine enhances antitumor efficacy through the induction of TRAIL and granzyme B expression.
Mohebbi A; Ebrahimzadeh MS; Baghban Rahimi S; Saeidi M; Tabarraei A; Mohebbi SR; Shirian S; Gorji A; Ghaemi A
Virus Res; 2019 Feb; 261():72-80. PubMed ID: 30599161
[TBL] [Abstract][Full Text] [Related]
19. Effective induction of antitumor immunity by immunization with plasmid DNA encoding TRP-2 plus neutralization of TGF-beta.
Jia ZC; Zou LY; Ni B; Wan Y; Zhou W; Lv YB; Geng M; Wu YZ
Cancer Immunol Immunother; 2005 May; 54(5):446-52. PubMed ID: 15750831
[TBL] [Abstract][Full Text] [Related]
20. Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human papillomavirus type 16 oncoproteins genetically fused to herpesvirus glycoprotein D.
Diniz MO; Lasaro MO; Ertl HC; Ferreira LC
Clin Vaccine Immunol; 2010 Oct; 17(10):1576-83. PubMed ID: 20739505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
